---
run_id: halo-evidence-vs-diagnosis-validation-v11-vanilla-long-prompt-07
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v11
benchmark_version: halo-evidence-vs-diagnosis-validation-v11-v1
model_condition: vanilla_long_prompt
run_number: 7
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 1024
seed: 704
prompt_source: condition packet (vanilla_long_prompt) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 18fa1d51f6167dbbf1f7ece676734d5cdb459384bca25e1508dd96cd4745e42d
source_packet: a neutral equal-length filler plus transition, then the frozen Advisor prompt; no substrate artifact - see run-packet.md
source_packet_sha256: b2788902c52d3bd202aee721889f5170e506802736ec9b70be6e014d6c8ff138
condition_packet_sha256: b2788902c52d3bd202aee721889f5170e506802736ec9b70be6e014d6c8ff138
output_file: model-outputs/vanilla_long_prompt-07.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - vanilla_long_prompt (run 07)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v11-v1`, condition `vanilla_long_prompt`, run 7 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 704, on the frozen condition packet.

## Output

I recommend the **Claim File Review**.

**Why:**
The current "strong quarter" is built on misleading indicators: expansion revenue was driven by temporary pricing bundles rather than organic value, and usage spikes are coming from managers reviewing closed files (administrative overhead) rather than adjusters managing live claims. Most critically, there is a "silent churn" occurring with regional carriers and a fundamental failure in the regulated health-liability segment due to lack of explainability.

The Usage Quality Sprint only measures *if* they return, and the Commercial Cleanroom only measures *if* they buy. Neither reveals *why* the product is being abandoned or overridden in practice. The Claim File Review provides the only ground-truth data on whether SignalPath is actually solving the problem or simply being "performed" for managers. This evidence is essential to decide if SignalPath requires a pivot in its logic (explainability) or if it is fundamentally flawed before you commit next year's budget to scaling a leaky bucket.

**The strongest reason against it:**
It is the slowest and most labor-intensive of the three validation options. Unlike a dashboard (Sprint) or a sales experiment (Cleanroom), it requires manual auditing of files and interviews with users, which may not provide a statistically significant sample size before the board locks the budget in twelve days.

**Observable evidence that would change my mind:**
If the "wrong recommendation" tickets in the training channel show a high correlation with specific, easily fixable UI/UX gaps rather than fundamental logic failures, I would pivot to the **Usage Quality Sprint**. If the data suggested that customers are buying based on the *promise* of the roadmap regardless of current utility, I would pivot to the **Commercial Cleanroom** to test the actual price elasticity and willingness to pay without the bundle.
